NCT05513664 2022-08-24Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung CancerShanghai JMT-Bio Inc.Unknown80 enrolled
NCT03219970 2021-09-14Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.AstraZenecaCompleted156 enrolled
NCT03370770 2020-12-24Afatinib Osimertinib Sequencing NISBoehringer IngelheimCompleted204 enrolled 10 charts
NCT03133234 2018-11-20Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLCAstraZenecaCompleted47 enrolled